The role of hydration in gut function
View as a Web Page
News Medical
 
  Gastroenterology Gastroenterology logo  
  The latest gastroenterology‎ news from News Medical  
 A breakthrough molecular discovery could neutralize gluten and protect coeliac patientsA breakthrough molecular discovery could neutralize gluten and protect coeliac patients
 
A research project led by the Institute for Research in Nutrition and Food Safety (INSA) and the Faculty of Pharmacy and Food Sciences at the University of Barcelona, together with the Molecular Biology Institute of Barcelona (IBMB) of the CSIC (which stands for Consejo Superior de Investigaciones Científicas), has successfully designed and tested a gluten-degrading molecule that is a promising ally in the management of coeliac disease, an...
 
 
 The role of hydration in gut functionThe role of hydration in gut function
 
Hydration and nutrition work together in digestion, influencing fiber tolerance, gut function, and digestive symptoms.
 
   Selective eating in autism linked to inflammatory gut bacteriaSelective eating in autism linked to inflammatory gut bacteria
 
Eating habits shape gut bacteria in children with autism, with potential dietary interventions offering hope for improving gut health and inflammation.
 
   Survey finds one in three women suffer silently with pelvic prolapseSurvey finds one in three women suffer silently with pelvic prolapse
 
Up to half of all women will experience some degree of pelvic organ prolapse in their lifetime. The condition can cause incontinence, constipation and the descent of the bladder or uterus into the vagina.
 
   Using AI to improve success rates of fecal microbiota transplantsUsing AI to improve success rates of fecal microbiota transplants
 
MOZAIC leverages deep learning to optimize fecal microbiota transplantation, enhancing treatment efficacy through precise donor-recipient microbiome matching.
 
 Immune-regulating molecule may offer new treatment approach for IBD patients
 
Immune-regulating molecule may offer new treatment approach for IBD patientsMayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, do not respond to commonly used therapies.
 
 
 Study challenges structural explanation for gut symptoms in hEDS patients
 
Study challenges structural explanation for gut symptoms in hEDS patientsA study, led by experts at the University of Nottingham, has found that persistent and distressing upper gut symptoms experienced by people with hypermobile Ehlers-Danlos syndrome (hEDS), are not due to structural problems with the gullet (esophagus), as previously assumed.
 
 
 Rhein protects against intestinal injury in severe acute pancreatitis
 
Rhein protects against intestinal injury in severe acute pancreatitisSevere acute pancreatitis (SAP) remains one of the most formidable challenges in gastrointestinal emergency medicine.
 
 
 Body weight and genes directly alter gut microbiota composition
 
Body weight and genes directly alter gut microbiota compositionYour body weight and genes influence the types of bacteria you have in your gut. In turn, this appears to affect the risk of developing conditions such as coeliac disease and haemorrhoids.
 
 
 Study Reveals New Biological Pathway for TNF-Resistant Crohn’s Disease
 
Study Reveals New Biological Pathway for TNF-Resistant Crohn’s DiseaseMayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, do not respond to commonly used therapies.
 
 
 New Data Suggest Ready-to-Eat Meats Rarely Reach Illness-Linked Bacterial Levels
 
New Data Suggest Ready-to-Eat Meats Rarely Reach Illness-Linked Bacterial LevelsThe study found that Clostridium perfringens was occasionally detected in raw or not-ready-to-eat meat products, but rarely appeared at concerning levels in cooked ready-to-eat meats. Even products linked to cooling deviations did not exceed 2 log CFU/g, suggesting that illness-associated growth during commercial stabilization is highly unlikely.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026